Anil Pareek

Dr Anil Pareek; (born 10 January 1957) is an Indian medical researcher with contributions in hypertension, metabolic disorder and inflammation. His prior experience includes academics and clinical practice. He is involved in drug development process targeting therapy gaps to create scope for innovative products.

Pareek is currently President, Medical Affairs and Clinical Research at Ipca Laboratories. Provided by Wikipedia
Showing 1 - 8 results of 8 for search 'Anil Pareek', query time: 0.10s Refine Results
  1. 1
    Compelling therapy of LVH: straight (and not-so-straight) inferences from evidence
    Get full text
    Article
  2. 2
    Hydroxychloroquine for prophylaxis in COVID-19: Need to revisit dosing regimen
    by Anil Pareek, Sudhir Bhandari, Ravi Tejraj Mehta
    Published 2020-01-01
    Get full text
    Article
  3. 3
    Chlorthalidone, not hydrochlorothiazide, is the right diuretic for comparison
    by Ravi Tejraj Mehta, Anil Pareek, Indranil Purkait
    Published 2018-03-01
    Get full text
    Article
  4. 4
    DAPA-HF study: Are the benefits uniform across non-diabetic subgroups
    Get full text
    Article
  5. 5
    Optimising TRIUMPH with 6·25 mg chlorthalidone
    Get full text
    Article
  6. 6
    REVEAL study: Reveals the limitations of cholesteryl ester transfer protein inhibition
    Get full text
    Article
  7. 7
    Cardiovascular safety of hydroxychloroquine: Brief appraisal of data
    Get full text
    Article
  8. 8
    Interamerican Society of Cardiology (IASC) position statement: Chlorthalidone vs. thiazide-type diuretics
    Get full text
    Article
Search Tools: Get RSS Feed — Email this Search